...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
【24h】

The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy

机译:糖皮质激素受体是前列腺癌细胞存活和改善抗抗原治疗的靶标的关键球员

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: The major obstacle in the management of advanced prostate cancer is the occurrence of resistance to endocrine therapy. Although the androgen receptor (AR) has been linked to therapy failure, the underlying escape mechanisms have not been fully clarified. Being closely related to the AR, the glucocorticoid receptor (GR) has been suggested to play a role in enzalutamide and docetaxel resistance. Given that glucocorticoids are frequently applied to prostate cancer patients, it is essential to unravel the exact role of the GR in prostate cancer progression.
机译:目的:晚期前列腺癌管理中的主要障碍是发生对内分泌治疗的抵抗力。 尽管雄激素受体(AR)与治疗失败有关,但潜在的逃避机制尚未完全澄清。 与AR密切相关,已提出糖皮质激素受体(GR)在烯醇酰胺和多西紫杉醇抗性中发挥作用。 鉴于糖皮质激素经常应用于前列腺癌患者,必须解开GR在前列腺癌进展中的确切作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号